Top 20 RNAi Therapeutic Companies Based on 2022 R&D Expenditure
PharmaShots
APRIL 25, 2023
In 2022, the global market size of RNAi drug delivery was valued at $69.2B. Even though the company manages to generate a considerable revenue of $21.18M in 2022 through its collaborative agreements, Silence Therapeutics still waiting for the approval of its products. In 2022, the company generated total revenue of $1.04B.
Let's personalize your content